Palo Alto, CA, United States of America

Volker Boehnert

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Location History:

  • Palo Alto, CA (US) (2023)
  • Stanford, CA (US) (2023)

Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Volker Boehnert: Innovator in Cancer Treatment

Introduction

Volker Boehnert is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of two patents, his work focuses on the development of ENPP1 inhibitors.

Latest Patents

Boehnert's latest patents revolve around ENPP1 inhibitors and their application in cancer treatment. These patents provide compounds, compositions, and methods for inhibiting ENPP1. The methods include contacting a sample with an ENPP1 inhibitor to inhibit the cGAMP hydrolysis activity of ENPP1. In certain instances, the ENPP1 inhibitor is cell impermeable. The patents also detail methods for treating cancer by administering a therapeutically effective amount of an ENPP1 inhibitor. This treatment is particularly relevant for solid tumor cancers. Additionally, the patents describe methods of administering radiation therapy either before or after the ENPP1 inhibitor, aiming to reduce radiation damage to the subject. The methods can be performed in combination with chemotherapeutic agents or checkpoint inhibitors.

Career Highlights

Volker Boehnert is affiliated with Leland Stanford Junior University, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for cancer patients.

Collaborations

Boehnert collaborates with notable colleagues, including Lingyin Li and Mark Smith, who contribute to his research endeavors.

Conclusion

Volker Boehnert's innovative work in developing ENPP1 inhibitors represents a significant advancement in cancer treatment. His contributions have the potential to enhance therapeutic strategies and improve patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…